Wilson Miller

Wilson Miller

McGill University - Montréal / Canada
Others
AD Scientific Index ID: 641463
person_outline Wilson Miller's MOST POPULAR ARTICLES
1-) Ipilimumab plus dacarbazine for previously untreated metastatic melanomaC Robert, L Thomas, I Bondarenko, S O\\\'Day, J Weber, C Garbe, C Lebbe, ...New England Journal of Medicine 364 (26), 2517-2526, 201149842011
2-) Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialA Hauschild, JJ Grob, LV Demidov, T Jouary, R Gutzmer, M Millward, ...The Lancet 380 (9839), 358-365, 201232092012
3-) Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trialJS Weber, SP D\\\'Angelo, D Minor, FS Hodi, R Gutzmer, B Neyns, ...The lancet oncology 16 (4), 375-384, 201525902015
4-) Talimogene laherparepvec improves durable response rate in patients with advanced melanomaRHI Andtbacka, HL Kaufman, F Collichio, T Amatruda, N Senzer, ...Journal of clinical oncology 33 (25), 2780-2788, 201527212015
5-) Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinomaRJ Motzer, K Penkov, J Haanen, B Rini, L Albiges, MT Campbell, ...New England Journal of Medicine 380 (12), 1103-1115, 201923812019